Amplify Bio is the first investor for a new generation of technical founders in the life sciences, backing them from the earliest stages as they build the digital platforms and infrastructure necessary to accelerate biological progress.
Axiom is helping eradicate drug toxicity by equipping scientists with AI models which are more accurate and more affordable than traditional physical experiments.
Axiom
Portfolio Spotlight
2
Learn More
Achira is building atomistic foundation simulation models to power the future of drug discovery.
Achira
Portfolio Spotlight
3
Learn More
Tahoe maps how chemistry perturbs biology to build a virtual model of the human cell.
Tahoe
Portfolio Spotlight
4
Learn More
"Amplify has been a close partner to us for years, and their Build Team's help with our go-to-market made a material impact on our trajectory."
Noga Leviner
Co-Founder and CEO
PicnicHealth
Portfolio Spotlight
5
Learn More
Chai is building frontier artificial intelligence to predict and reprogram the interactions between biochemical molecules.
Chai
Portfolio Spotlight
6
Learn More
Bexorg transforms entire brains into molecular and interventional platforms, enabling us to explore the brain in unprecedented ways.
Bexorg
Our Manifesto
We are in the age of Digital Biology – software and AI are starting to transform science. Modern life science labs have become some of the largest data generators on the planet. A new generation of technical founders, equally fluent in compute and biology, is leading this revolution; we’re building Amplify Bio to support them from day one.
.avif)
.webp)
